Human Protein Atlas adopts Origene's Over-expression Lysates | GenomeWeb

This story originally ran on Nov. 11.

The operators of the Human Protein Atlas program have adopted Origene Technologies' Verify Tagged Antigen over-expression lysates, the Rockville-based company said this week.

The HPA, operated by the Royal Institute of Technology in Stockholm, is a project to map the human proteome using antibody-based technologies. Origene's Verify Tagged Antigen over-expression lysates are full-length human proteins for functional studies and antibody validation, according to the company's website.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.